How to Pay Less for Prescription Drugs in 2026

An estimated 130 million Americans take at least one prescription drug, and 29% report not filling a prescription in the past year because of cost—most without knowing the alternatives available to them. Generic strategies, discount programs, and direct-to-consumer pharmacies can cut typical drug costs by 50 to 90%. This guide covers every major strategy, who it works for, and how to use it.

1. Generic vs. brand-name drugs

Generic drugs contain the same active ingredient, strength, dosage form, and route of administration as their brand-name counterparts. The FDA requires generics to be bioequivalent—meaning they are absorbed into the bloodstream at the same rate and to the same extent as the original. They are not inferior medications. The price difference is purely the result of economics: brand manufacturers recover research and development costs during their patent exclusivity period, after which any manufacturer can produce the generic.

Generics cost 80 to 85% less than brand-name drugs on average, according to the FDA. The practical impact for patients is enormous:

Always ask your prescriber: “Is there a generic available for this medication?” and “Would the generic work for my situation?” For most chronic conditions, the generic works identically. The main exceptions are a small number of narrow therapeutic index drugs (certain thyroid medications, epilepsy drugs) where your doctor may prefer to keep you on a consistent formulation.

2. GoodRx, Blink Health, and discount card programs

GoodRx is a free service that negotiates discounted rates with pharmacy benefit managers and passes those savings to users. You do not need insurance to use it—simply show the GoodRx coupon (app or printed) at the pharmacy counter. GoodRx is accepted at most major pharmacy chains and many independent pharmacies.

GoodRx works best for generic medications. For brand-name drugs, the discount is typically modest. Prices vary significantly by pharmacy, so always compare prices across nearby locations in the app before filling.

When GoodRx may NOT be your best option:

• Your insurance copay is already lower than the GoodRx price (common for Tier 1 generics on good plans).
• You are close to your out-of-pocket maximum—using GoodRx means the spend doesn’t count toward your OOP max.
• The drug qualifies for a manufacturer copay card that reduces your cost to $0 or near-zero.

Alternatives to GoodRx:

3. Mark Cuban’s Cost Plus Drugs and direct-to-consumer options

Cost Plus Drugs, launched in 2022, operates on a radical transparency model: it charges the actual manufacturing cost of the drug plus a flat 15% markup plus a dispensing fee. For generic medications, this can be dramatically cheaper than any other option. The service requires a valid prescription from your doctor but does not require insurance.

Examples of Cost Plus Drugs pricing compared to retail:

• Imatinib 400mg (generic Gleevec, leukemia): $19/month vs. $9,000+ retail
• Tamoxifen 20mg (breast cancer prevention): $5/month vs. $150+ retail
• Rosuvastatin 10mg (Crestor generic): $4/month vs. $40+ retail
• Metformin ER 1000mg (diabetes): $6/month vs. $25+ retail

Cost Plus Drugs is a mail-order pharmacy, so it works best for maintenance medications you refill regularly. It does not carry every drug, and it does not carry brand-name medications. Check availability before transferring a prescription.

4. Manufacturer patient assistance programs

Every major pharmaceutical manufacturer offers a patient assistance program (PAP) for brand-name drugs that provides free or heavily discounted medication to patients who cannot afford it. These programs are separate from and usually more generous than the copay cards marketed to commercially insured patients.

Major programs by manufacturer include:

• Pfizer RxPathways — covers Eliquis, Ibrance, Xeljanz, and others for eligible patients
• Lilly Cares Foundation — covers Humalog, Trulicity, Jardiance, Taltz, and more; insulin at $35/month for eligible patients
• Novo Nordisk Patient Assistance — covers Ozempic, Victoza, Tresiba, and other insulins
• AstraZeneca AZ&Me — covers Farxiga, Brilinta, and other AZ medications
• Bristol Myers Squibb Patient Assistance Foundation — covers Eliquis (co-sponsored with Pfizer), Opdivo, and others

Most programs require income at or below 200–400% of the federal poverty level and U.S. residency. Applications are typically submitted by your doctor’s office. NeedyMeds.org maintains a free, searchable database of over 4,000 assistance programs—search by drug name to find the specific program and eligibility criteria.

5. 90-day supply, pill splitting, and OTC switches

90-day supply: For any maintenance medication (taken daily for a chronic condition), switching from a 30-day supply to a 90-day mail-order fill typically reduces cost per dose by 20 to 33%. Most health plans encourage this through lower copays on mail-order 90-day fills. Ask your doctor to write prescriptions for 90-day supplies with refills for all chronic medications.

Pill splitting: For medications where double-strength tablets cost approximately the same as single-strength, your doctor may prescribe double-strength tablets and instruct you to split them with an inexpensive pill splitter. This effectively doubles your supply at the same cost. This works for certain blood pressure medications, statins, and antidepressants where the tablet is scored and splittable. Never split capsules, extended-release tablets, or enteric-coated tablets without your doctor’s explicit guidance.

Over-the-counter switches: Several drugs that previously required a prescription are now available over-the-counter (OTC) at a lower cost than the prescription version:

• Cetirizine (Zyrtec): OTC generic ~$10/month vs. prescription allergy medications
• Loratadine (Claritin): OTC generic ~$5/month
• Fluticasone nasal spray (Flonase): OTC ~$15/month vs. prescription alternatives
• Omeprazole (Prilosec): OTC generic ~$8/month vs. prescription Nexium or Dexilant
• Miconazole, clotrimazole: OTC antifungals vs. prescription alternatives

In some cases, your insurance will not cover the OTC version even if a prescription form exists, so the OTC version may be cheaper out of pocket. Confirm with your pharmacist.

6. Working your insurance plan harder

Most patients accept the tier their drug is placed on without realizing they have options to lower cost-sharing through their insurance plan itself.

1. Request a formulary exception. If your drug is on Tier 3 or Tier 4, you or your doctor can request a formulary exception to have it covered at a lower tier, citing medical necessity. This works when you have tried lower-tier alternatives and they were ineffective or caused adverse effects.
2. Request a tier exception. A tier exception asks the plan to apply a lower tier’s cost-sharing to your specific drug without changing its formulary placement. Most plans allow one exception per plan year with physician documentation.
3. Ask your doctor for samples. Physician offices receive free samples of brand-name medications from pharmaceutical representatives. A 2–4 week sample supply can bridge the gap while you apply for assistance or await a prior authorization decision.
4. Appeal a prior authorization denial. If your insurer denied a prior auth for a medication your doctor prescribed, you can appeal with clinical documentation. An urgent/expedited appeal must receive a decision within 72 hours. See our guide on appealing insurance denials.
5. Use manufacturer copay cards for commercially insured patients. For expensive brand-name drugs (CGRP migraine drugs, GLP-1s, biologics), manufacturers offer copay assistance cards that reduce your out-of-pocket to $0–35/month for commercially insured patients. These are not available to Medicare or Medicaid beneficiaries.

7. Government programs: Medicare Extra Help, SPAP, insulin cap

Medicare Extra Help (Low Income Subsidy): Medicare beneficiaries with limited income and assets may qualify for the Extra Help program, which significantly reduces Part D premiums, deductibles, and copays. In 2026, eligible beneficiaries pay $0 to $11 per prescription. An estimated 3 million Medicare beneficiaries who qualify for Extra Help have not enrolled. Apply through SSA.gov or your State Health Insurance Assistance Program (SHIP).

State Pharmaceutical Assistance Programs (SPAPs): Many states operate their own drug assistance programs for residents who fall into the gap between Medicaid and full Medicare coverage. Eligibility and benefits vary by state. The Medicare Rights Center maintains a directory of SPAP programs at medicarerights.org.

$35/month insulin cap: The Inflation Reduction Act capped Medicare Part D insulin cost-sharing at $35 per month per insulin. Most ACA-compliant commercial plans apply a similar cap. If you are paying more than $35/month for insulin through an insured plan, contact your insurer immediately—this is likely a billing or adjudication error that they are required to correct.

Medicaid and CHIP: If your income is at or below 138% of the federal poverty level, you likely qualify for Medicaid, which covers most medications at minimal or no cost. Use healthcare.gov to check eligibility.

8. Strategy comparison table

Frequently asked questions

Sources

• FDA: Generic Drug Facts — Bioequivalence and Safety
• KFF: Cost-Related Medication Nonadherence in the United States
• CMS: Medicare Extra Help (Low Income Subsidy) Program
• Mark Cuban Cost Plus Drug Company — Pricing Methodology
• NeedyMeds: Patient Assistance Program Database
• Inflation Reduction Act of 2022 — Medicare Drug Price Negotiation and Insulin Cap
• Health Affairs: Impact of Cost Plus Drugs on Prescription Drug Affordability